Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Grand Brilliance Group Holdings PEG Ratio?
Grand Brilliance Group HoldingsHKSE:08372 66 PEG Ratio is 6.08 as of Aug. 09, 2026, which is 17% below its 10-year median of 7.33. GuruFocus rates HKSE:08372 with a GF Score™ of 66/100 and a GF Value™ of HK$0.12 (Fairly Valued). The stock has 5 warning signs investors should review. Among 49 Medical Distribution companies, Grand Brilliance Group Holdings ranks worse than 83.67% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Grand Brilliance Group Holdings's PEG Ratio or its related term are showing as below:
HKSE:08372'
s PEG Ratio Range Over the Past 10 Years
Min: 1.88 Med: 7.33 Max: 65.72
Current: 6.08
During the past 11 years, Grand Brilliance Group Holdings's highest PEG Ratio was 65.72. The lowest was 1.88. And the median was 7.33.
HKSE:08372's PEG Ratio is ranked worse than 83.67% of 49
companies
in the Medical Distribution industry
Industry Median: 1.99
vs HKSE:08372: 6.08
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Grand Brilliance Group Holdings (HKSE:08372) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Grand Brilliance Group Holdings PEG Ratio Related Terms
Grand Brilliance Group Holdings PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Grand Brilliance Group Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Brilliance Group Holdings PEG Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Grand Brilliance Group Holdings's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Grand Brilliance Group Holdings (HKSE:08372) has a PEG Ratio of 6.08 as of Aug. 09, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Grand Brilliance Group Holdings and its competitors. This is 17% below median its historical median of 7.33. Over the past decade, Grand Brilliance Group Holdings' PEG Ratio has ranged from 1.88 to 65.72. According to the industry distribution chart, Grand Brilliance Group Holdings ranks #41 out of 49 companies in the Medical Distribution industry, placing it in the top 83.7%.
Is Grand Brilliance Group Holdings' PEG Ratio too high?
Grand Brilliance Group Holdings' current PEG Ratio of 6.08 is 17% below median its 10-year median of 7.33. Over the past 10 years, this metric has ranged from a low of 1.88 to a high of 65.72. The Medical Distribution industry median PEG Ratio is 1.99. Grand Brilliance Group Holdings' value of 6.08 is 205.5% above this industry median. Based on the distribution chart, Grand Brilliance Group Holdings ranks #41 out of 49 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Grand Brilliance Group Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grand Brilliance Group Holdings' PEG Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Grand Brilliance Group Holdings ranks #41 out of 49 companies for PEG Ratio. This places Grand Brilliance Group Holdings in the lower half of its industry. The industry median PEG Ratio is 1.99. Grand Brilliance Group Holdings' value of 6.08 is 205.5% above this benchmark. Historically, Grand Brilliance Group Holdings' own PEG Ratio has ranged from 1.88 to 65.72 over the past decade. While the company's 10-year median is 7.33 vs. the industry median of 1.99, Grand Brilliance Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.99, based on 49 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Brilliance Group Holdings's current PEG Ratio of 6.08 is 205.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Grand Brilliance Group Holdings and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Brilliance Group Holdings's current PEG Ratio is 6.08, which is 17% below median its own 10-year median of 7.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Brilliance Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings (HKSE:08372) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.13 — trading 5.8% above its estimated fair value. The current PEG Ratio is 6.08, which is 17% below median its 10-year median of 7.33 and 205.5% above the Medical Distribution industry median of 1.99. Grand Brilliance Group Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Grand Brilliance Group Holdings (HKSE:08372), the current PEG Ratio is 6.08 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grand Brilliance Group Holdings (HKSE:08372) Overvalued in 2026?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 5.8% above its estimated GF Value™ of HK$0.12.
GuruFocus considers Grand Brilliance Group Holdings to be Fairly Valued.
Key valuation signals for HKSE:08372:
PEG Ratio: 6.08 (17% below median its 10-year median of 7.33)
GF Value™: HK$0.12 vs. price of HK$0.13 (5.8% above fair value)
Industry Position: 205.5% above the Medical Distribution median (#41 of 49)
No single metric tells the full story. See the HKSE:08372 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. It serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
66GF Score
Get the complete analysis for HKSE:08372
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08372 has been successfully added to your 
